Adage Capital Partners Gp, L.L.C. Inozyme Pharma, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,673,629 shares of INZY stock, worth $15.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,673,629

Previous 5,728,856 0.96%

Holding current value

$15.9 Million

Previous $25.6 Million 16.14%

% of portfolio

0.05%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.31 - $6.0 $238,028 - $331,362	-55,227 Reduced 0.96%	5,673,629 $29.7 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $7.31 $1.73 Million - $2.92 Million	400,000 Added 7.51%	5,728,856 $25.6 Million
Q1 2024 May 15, 2024	SELL	$4.14 - $7.66 $863,786 - $1.6 Million	-208,644 Reduced 3.77%	5,328,856 $40.8 Million
Q3 2023 Nov 14, 2023	BUY	$4.09 - $7.0 $5.27 Million - $9.01 Million	1,287,500 Added 30.29%	5,537,500 $23.3 Million
Q2 2023 Aug 14, 2023	SELL	$4.93 - $6.74 $74,630 - $102,030	-15,138 Reduced 0.35%	4,250,000 $23.7 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $1.51 Million - $6.68 Million	1,165,000 Added 37.58%	4,265,138 $24.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.05 - $2.82 $528,639 - $1.42 Million	503,466 Added 19.39%	3,100,138 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$2.57 - $5.45 $128,499 - $272,500	50,000 Added 1.96%	2,596,672 $6.96 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.96 $2.56 Million - $4.77 Million	800,000 Added 45.8%	2,546,672 $12.1 Million
Q1 2022 May 16, 2022	BUY	$3.87 - $7.55 $571,382 - $1.11 Million	147,644 Added 9.23%	1,746,672 $7.14 Million
Q4 2021 Feb 14, 2022	BUY	$5.58 - $11.5 $732,096 - $1.51 Million	131,200 Added 8.94%	1,599,028 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$11.12 - $19.4 $1.99 Million - $3.48 Million	179,156 Added 13.9%	1,467,828 $17 Million
Q2 2021 Aug 16, 2021	BUY	$15.19 - $21.2 $3.02 Million - $4.22 Million	199,000 Added 18.26%	1,288,672 $22 Million
Q1 2021 May 17, 2021	BUY	$17.77 - $27.9 $3.43 Million - $5.38 Million	193,000 Added 21.52%	1,089,672 $21.6 Million
Q4 2020 Feb 16, 2021	BUY	$19.95 - $27.55 $1.93 Million - $2.66 Million	96,672 Added 12.08%	896,672 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$17.54 - $30.2 $14 Million - $24.2 Million	800,000 New	800,000 $21 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

53M

Call Options Held

3.7K

Put Options Held

5.8K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $113M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Inozyme Pharma, Inc. Transaction History